Recent news
March 2010
Glaxo to extend flexible drug pricing program to middle-income countries
Pharmaceutical company GlaxoSmithKline has announced that it plans to boost sales in middle-income countries and reduce prices in some of the world’s poorest nations. See below for more information.
